30th Jun 2006 16:06
Cambridge Antibody Tech Group PLC30 June 2006 30 June 2006 Cambridge Antibody Technology Group plc ("CAT") Delisting AstraZeneca UK Limited announced on 22 June 2006, that its recommended offer forCAT had been declared unconditional in all respects. Application has been made by CAT to the UKLA for the cancellation of CAT'slisting on the Official List of the UKLA and to the London Stock Exchange forthe cancellation of the admission to trading of CAT shares on the London StockExchange's market for listed securities. It is anticipated that cancellation oflisting and admission to trading will take effect from 28 July 2006, being 20business days following the date of this announcement. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
CATCo